Connie L. Batlevi, MD, PhD, discusses the efficacy of tazemetostat in patients with follicular lymphoma and an EZH2 mutation.
Connie L. Batlevi, MD, PhD
Connie W. Batlevi (Lee), MD, PhD, is an oncologist in New York, NY, and is affiliated with Memorial Sloan Kettering Cancer Center.
Articles by Connie L. Batlevi, MD, PhD